1. Introduction

Cross-border telemedicine prescribing conflicts arise when a medical practitioner located in one country electronically prescribes medicines to a patient located in another country, and the two countries have different laws governing medical registration, prescribing authority, pharmaceutical approvals, controlled substances, online pharmacies, patient safety and professional liability.

For example:

A doctor registered in the United States prescribes medication to a patient residing in India.

An Indian doctor provides an online consultation to a patient living in Australia and issues an electronic prescription.

A doctor in the United Kingdom prescribes a medicine that is not approved for sale in the patient's country.

A telemedicine platform connects a patient in one jurisdiction with a specialist in another jurisdiction who prescribes controlled medication.

These situations create a conflict between the law of the doctor's location and the law of the patient's location.

The central legal question is:

Can a doctor who is legally authorised to prescribe medicines in one country lawfully issue a prescription to a patient in another country where the doctor may not be registered or where the prescribed medicine may be restricted or prohibited?

The issue involves private international law, medical licensing, pharmaceutical regulation, electronic commerce, consumer protection, data protection and cross-border professional accountability.

2. Meaning and Nature of Cross-Border Prescribing Conflicts

A cross-border prescribing conflict occurs when a prescription issued through electronic communication crosses national boundaries and encounters inconsistent legal requirements.

The conflict may involve several independent legal questions:

Whether the doctor is legally authorised to practise in the patient's country.

Whether the doctor can prescribe without obtaining local medical registration.

Whether the medicine is approved in the patient's country.

Whether the prescription satisfies local formal and electronic-prescription requirements.

Whether controlled drugs can legally be prescribed and transported across borders.

Whether a foreign prescription can be dispensed by a domestic pharmacy.

Which country's law governs medical negligence.

Which court has jurisdiction over a prescribing dispute.

Whether disciplinary or civil judgments can be enforced abroad.

Whether patient medical records can lawfully be transferred internationally.

Importantly, recognition of a foreign medical qualification does not automatically confer prescribing authority in another country. Likewise, recognition of an electronic prescription does not necessarily establish that the underlying medical consultation was lawful.

3. Principal Sources of Law

The legal framework generally consists of the following categories.

4. Jurisdictional Conflict: Doctor's Country Versus Patient's Country

This is the most important issue in cross-border telemedicine prescribing.

Two competing jurisdictional principles may apply.

A. Law of the doctor's location (lex loci actus)

Under this approach, the doctor's professional conduct is assessed partly by the law of the country where the doctor is physically located.

For example, if an American doctor conducts a consultation from California, California's medical licensing and professional conduct rules may apply to that doctor.

B. Law of the patient's location (patient-protection principle)

Under this approach, the country where the patient receives medical treatment has a substantial regulatory interest.

The patient's country may require the foreign doctor to:

Obtain local registration.

Comply with domestic prescribing restrictions.

Follow local standards of medical practice.

Maintain appropriate professional indemnity insurance.

Observe local pharmaceutical and controlled-drug requirements.

The Medical Board of Australia expressly addresses this problem. It expects doctors treating patients located in Australia to be registered in Australia regardless of where the doctor is physically located. Australian doctors treating patients abroad must also determine whether registration is required in the patient's country.

Telehealth consultations with patients

C. Practical legal position

The safest approach is to distinguish three separate locations:

The doctor's physical location.

The patient's physical location during the consultation.

The pharmacy's location where the medicine is dispensed.

Each location can trigger different legal obligations. The pharmacy's country may impose additional rules even where the doctor and patient are legally permitted to participate in telemedicine.

5. Medical Licensing and Registration Conflicts

Medical licensing is a central issue because professional registration is generally territorial.

A doctor who is authorised to practise in one jurisdiction does not automatically acquire the right to practise in another jurisdiction.

For example:

An Indian-registered doctor cannot automatically practise medicine in the United States merely because the consultation occurs online.

A US-registered doctor cannot automatically prescribe to an Australian patient without considering Australian registration requirements.

A British specialist cannot assume that registration with the General Medical Council authorises unrestricted clinical practice in India.

Legal consequences

Unauthorised cross-border prescribing may result in:

Civil liability for unlawful medical practice.

Administrative penalties.

Professional disciplinary proceedings.

Criminal prosecution where domestic legislation creates an offence.

Injunctions against the telemedicine platform.

Restrictions on prescription transmission and dispensing.

The distinction between providing an academic second opinion and directly treating a patient is important. A specialist who advises the patient's local treating doctor may occupy a different legal position from a foreign doctor who independently diagnoses, prescribes and manages the patient.

6. Pharmaceutical Approval and Drug-Market Conflicts

A prescription may be valid under the law of the prescribing country but involve a medicine that is not authorised in the patient's country.

For example, a foreign doctor may prescribe a medicine that:

Has not received domestic marketing authorisation.

Has been withdrawn for safety reasons.

Is restricted to hospital use.

Requires special import permission.

Is classified as a controlled substance.

Is subject to additional monitoring requirements.

The prescription and the medicine's legal status must therefore be examined separately.

Important principle: A valid foreign prescription does not automatically authorise the importation, possession or domestic sale of the prescribed medicine.

The destination country may apply its own rules under pharmaceutical legislation, customs law and controlled-substances legislation.

7. Electronic Prescription Recognition

Electronic prescriptions create a further legal conflict.

Different jurisdictions have different requirements regarding:

Digital signatures.

Doctor identification.

Medical registration numbers.

Prescription authentication.

Electronic record retention.

Pharmacy verification.

Prescription validity periods.

Patient consent.

Drug substitution.

The European Union provides an important example of cross-border prescription recognition.

Article 11 of Directive 2011/24/EU requires Member States, subject to specified safeguards, to recognise prescriptions issued in another Member State for medicines authorised in their territory. Recognition does not eliminate national prescribing and dispensing rules.

EUR-Lex+1

Commission Implementing Directive 2012/52/EU provides measures facilitating recognition of medical prescriptions issued in another Member State.

The EU model demonstrates that cross-border recognition can be legally facilitated without completely harmonising national pharmaceutical laws.

8. Controlled Drugs and Psychotropic Substances

Controlled substances create particularly serious prescribing conflicts.

Examples include:

Opioid analgesics.

Certain sedatives.

Benzodiazepines.

Stimulant medicines.

Narcotic and psychotropic substances.

A doctor may be legally entitled to prescribe a controlled drug in the country of consultation, but the patient's country may prohibit or restrict the prescription, importation or possession of that substance.

Relevant international instruments include:

Single Convention on Narcotic Drugs, 1961.

Convention on Psychotropic Substances, 1971.

United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988.

These instruments establish international controls, but domestic implementation determines many practical prescribing and dispensing requirements.

A telemedicine platform cannot avoid these restrictions merely by electronically transmitting a prescription across a national boundary.

9. Indian Legal Framework

India provides an important example of the difficulties in regulating cross-border telemedicine.

A. Telemedicine Practice Guidelines, 2020

The Ministry of Health and Family Welfare issued the Telemedicine Practice Guidelines on 25 March 2020.

The guidelines were incorporated into the professional ethics framework for registered medical practitioners.

Important requirements include:

Verification of the identity of the doctor and patient.

Identification of the doctor's medical registration number.

Appropriate patient consent.

Adequate clinical evaluation.

Professional judgment about whether remote consultation is appropriate.

Compliance with prescribing restrictions.

Maintenance of medical records.

Protection of patient confidentiality.

Referral for physical examination when necessary.

The guidelines permit registered medical practitioners to provide telemedicine consultations to patients from any part of India. However, this is an internal Indian permission, not a general international medical-practice licence.

Ministry of Health and Family Welfare+1

B. Important limitation: Foreign patients and foreign doctors

The Indian Telemedicine Practice Guidelines specifically exclude teleconsultations outside India's jurisdiction from their stated scope.

Consequently, they should not be interpreted as automatically authorising an Indian doctor to provide unrestricted telemedicine services to a patient located abroad.

Similarly, a foreign doctor cannot assume that a foreign medical registration automatically authorises independent clinical practice in India.

This creates a regulatory gap requiring examination of the relevant foreign country's legislation and India's applicable medical-practice requirements.

PubMed Central (PMC)+1

C. Drugs and Cosmetics Act, 1940

The Drugs and Cosmetics Act, 1940, and Drugs Rules, 1945, regulate the manufacture, import, sale and distribution of medicines.

Their relevance to cross-border prescribing includes:

Import restrictions on medicines.

Prescription requirements for specified drug categories.

Restrictions on sale of prescription-only medicines.

Regulation of pharmacies and drug sellers.

Restrictions relating to prohibited or unapproved medicines.

A foreign prescription does not displace the applicable Indian requirements for lawful importation and dispensing.

D. Narcotic Drugs and Psychotropic Substances Act, 1985

The NDPS Act regulates narcotic drugs and psychotropic substances.

Cross-border telemedicine prescribing involving such substances may raise issues of:

Unauthorised prescribing.

Illegal importation.

Possession without lawful authority.

Unlawful distribution.

International trafficking.

The doctor's foreign professional authorisation is not, by itself, a defence to an offence under applicable Indian law.

E. National Medical Commission Act, 2019

The National Medical Commission Act, 2019, provides the statutory framework for medical registration and professional regulation in India.

Foreign medical qualifications, registration and permission to practise must be considered under the applicable statutory framework. A foreign doctor providing treatment directly to a patient in India cannot simply rely on internet-based communication to avoid medical registration requirements.

10. Important Case Laws and Judicial Principles

There is no comprehensive body of judicial decisions specifically dealing with every form of cross-border telemedicine prescribing. However, several judgments establish principles directly relevant to licensing, jurisdiction, medical negligence and pharmaceutical regulation.

Case 1. Hageseth v. Superior Court (2007)

California Court of Appeal · A115390 · 21 May 2007

Facts:

Dr Christian Hageseth was located in Colorado and held a Colorado medical licence. He issued an online prescription for fluoxetine to a California resident after receiving an online questionnaire.

The patient obtained the medicine through a pharmacy in Mississippi. The doctor had not personally visited California or directly communicated with the patient there.

The California authorities charged him with practising medicine without a California licence.

Legal issue:

Could California exercise criminal jurisdiction over a doctor who issued a prescription from another state through the internet?

Judgment:

The California Court of Appeal rejected the doctor's jurisdictional challenge.

It held that the prescribing conduct could be treated as occurring in California because the prescription was intended to produce, and did produce, effects in California.

The fact that the doctor acted through internet communications and intermediaries did not defeat territorial jurisdiction.

Legal principles:

Internet-based medical prescribing can constitute the practice of medicine in the patient's jurisdiction.

Physical presence of the doctor is not necessarily required for territorial jurisdiction.

A foreign or out-of-state medical licence does not automatically authorise prescribing in another jurisdiction.

Intermediaries do not necessarily prevent the destination jurisdiction from exercising authority.

Significance:

This is one of the most important decisions for cross-border telemedicine prescribing conflicts.

It demonstrates that a doctor may face legal consequences in the patient's jurisdiction even when the doctor never physically enters that jurisdiction.

Justia Law+1

Case 2. State ex rel. Attorney General v. DVM Enterprises, Inc. (2003)

Supreme Court of Kansas · 275 Kan. 243 · 62 P.3d 653

Facts:

The dispute concerned internet-based pharmaceutical activities involving prescriptions and delivery of prescription drugs into Kansas.

Legal issue:

Could a state restrict an internet pharmaceutical business from delivering prescription medicines into its territory without satisfying local medical licensing requirements?

Judicial principle:

The Kansas proceedings supported enforcement measures preventing unlawful prescription-drug delivery into the state.

The decision is particularly relevant because the court recognised that internet-based pharmaceutical operations do not become immune from domestic regulation merely because their operators are located elsewhere.

Significance:

The case illustrates the relationship between:

Medical licensing.

Online pharmaceutical distribution.

Territorial enforcement.

Consumer protection.

State regulatory authority.

It also demonstrates why telemedicine platforms must consider the destination jurisdiction before facilitating prescriptions and medicine delivery.

Justia Law+1

Case 3. Jacob Mathew v. State of Punjab (2005)

Supreme Court of India · (2005) 6 SCC 1

Facts:

The case concerned allegations of medical negligence against medical practitioners following the death of a patient.

Legal issue:

What standard should be applied when determining criminal liability for medical negligence?

Judgment:

The Supreme Court explained that criminal liability for medical negligence requires a substantially higher degree of negligence than ordinary civil negligence.

The judgment discussed the requirement of gross negligence or recklessness for criminal prosecution of a medical professional.

Principles relevant to telemedicine:

Medical practitioners must exercise reasonable professional care.

A departure from the applicable professional standard may create civil liability.

Criminal liability cannot be imposed merely because treatment produces an unsuccessful outcome.

The limitations and circumstances of medical practice are relevant when evaluating negligence.

Cross-border application:

Where a foreign doctor prescribes medication remotely to an Indian patient, the applicable negligence standard and jurisdiction must be separately determined.

The judgment provides an important Indian foundation for evaluating professional negligence in telemedicine disputes.

Case 4. Indian Medical Association v. V.P. Shantha (1995)

Supreme Court of India · (1995) 6 SCC 651

Facts:

The case examined whether medical services could fall within the definition of services under the Consumer Protection Act, 1986.

Legal issue:

Could patients bring consumer-protection proceedings against medical practitioners and healthcare institutions?

Judgment:

The Supreme Court recognised that medical services may fall within consumer-protection legislation, subject to the distinctions and exceptions explained in the judgment.

Relevance to cross-border prescribing:

A patient who receives paid telemedicine services may have consumer-law remedies where the relevant jurisdiction and statutory requirements are satisfied.

Potential disputes include:

Defective online consultations.

Misleading claims about medical qualifications.

Unauthorised prescription services.

Inadequate professional advice.

Deficiencies in medical service delivery.

The judgment is important for understanding the consumer dimension of telemedicine, although it does not itself decide an international telemedicine dispute.

Case 5. Smits and Peerbooms v. Stichting Ziekenfonds and Stichting CZ Groep Zorgverzekeringen (2001)

Court of Justice of the European Communities · Case C-157/99

Facts:

The dispute concerned Dutch patients who received medical treatment in Germany and subsequently sought reimbursement under their domestic healthcare arrangements.

Legal issue:

Could a Member State impose restrictions on obtaining healthcare in another Member State?

Judgment:

The Court recognised that prior authorisation requirements could restrict the freedom to receive cross-border medical services, but certain restrictions could be justified by legitimate healthcare-system objectives.

Relevance:

The case establishes an important European principle: cross-border healthcare services involve a balance between individual access to treatment and the legitimate regulatory interests of national healthcare systems.

It provides a broader foundation for analysing international telemedicine services, although it does not directly determine the validity of a foreign doctor's prescription.

CP0132en

Case 6. Rogers v. Whitaker (1992)

High Court of Australia · (1992) 175 CLR 479

Facts:

The case involved an ophthalmologist who performed surgery without adequately warning the patient of a material risk.

Legal issue:

What is the duty of a medical practitioner to disclose material risks to a patient?

Judgment:

The High Court recognised that doctors have a duty to disclose material risks that a reasonable person in the patient's position would likely consider significant, subject to the circumstances of the case.

Relevance to cross-border prescribing:

A doctor prescribing medicines remotely must provide adequate information about:

Material adverse effects.

Drug interactions.

Significant contraindications.

Treatment alternatives.

Monitoring requirements.

Relevant limitations of remote assessment.

The judgment is particularly relevant where a patient alleges that a foreign telemedicine practitioner failed to explain the risks of a prescribed medicine.

It is not a cross-border licensing decision, but its informed-consent principles are important in international telemedicine litigation.

Case 7. Bolam v. Friern Hospital Management Committee (1957)

Queen's Bench Division · [1957] 1 WLR 582

Facts:

The case concerned medical treatment and the standard of professional care expected from a doctor.

Legal issue:

How should courts evaluate whether a medical practitioner has acted negligently?

Judgment:

The traditional Bolam principle states that a doctor is generally not negligent if acting in accordance with a responsible body of medical opinion, subject to subsequent judicial developments and qualifications.

Relevance:

For remote prescribing, courts may examine whether the doctor followed a professionally acceptable process for:

Establishing a diagnosis.

Reviewing medical history.

Checking contraindications.

Selecting medication.

Monitoring the patient.

Arranging physical examination when necessary.

The applicable domestic negligence law must still be identified in an international dispute.

Case 8. Bolitho v. City and Hackney Health Authority (1997)

House of Lords · [1998] AC 232

Facts:

The dispute concerned a doctor's failure to attend a child experiencing respiratory difficulties and the medical consequences of that failure.

Legal issue:

Must courts automatically accept a professional medical opinion when assessing negligence?

Judgment:

The House of Lords explained that professional medical opinion must have a logical basis and be capable of withstanding judicial scrutiny.

Relevance:

A foreign doctor cannot necessarily defend an unsafe remote prescription merely by arguing that another medical practitioner might have prescribed the same medicine.

Courts may examine whether the clinical decision was logically defensible in the circumstances.

These negligence principles complement the licensing and jurisdiction principles established in Hageseth.

11. Private International Law: Which Country's Law Applies?

Cross-border telemedicine prescribing may generate disputes in several countries simultaneously.

The court must determine the applicable law through private international law principles.

A. Lex loci delicti (law of the place of the wrong)

This principle generally connects a tort claim with the jurisdiction where the relevant wrongful conduct or legally significant injury occurred.

For example, if an overseas doctor negligently prescribes medication to an Indian patient and the patient suffers injury in India, Indian law may become relevant.

However, the precise choice-of-law test depends on the forum's private international law rules.

B. Lex fori (law of the forum)

The law of the court hearing the dispute governs procedural questions and may also govern particular issues where its conflict-of-laws rules so provide.

C. Proper law of the contract

Where the patient enters into a telemedicine agreement with an overseas healthcare provider, the court may examine:

The governing-law clause.

The place of contracting.

The parties' intentions.

The place of performance.

Mandatory consumer-protection rules.

A contractual choice-of-law clause cannot necessarily exclude mandatory medical licensing, pharmaceutical or patient-protection legislation.

D. Objective territorial jurisdiction

A country may claim jurisdiction where conduct outside its territory produces legally significant consequences within its territory.

The reasoning in Hageseth v. Superior Court illustrates this approach.

12. Cross-Border Medical Negligence and Liability

Foreign prescribing may produce different categories of liability.

Illustration:

A doctor in the United Kingdom prescribes a medicine to an Indian patient without checking the patient's existing medication.

The patient experiences a serious drug interaction.

Potential legal questions include:

Whether the doctor was authorised to treat the patient in India.

Whether the prescription complied with applicable UK and Indian requirements.

Whether the doctor obtained sufficient medical history.

Whether the interaction was reasonably foreseeable.

Whether the patient was adequately informed.

Whether the doctor had appropriate professional indemnity coverage.

Which country's courts can hear the negligence claim.

Importantly, the existence of a foreign medical licence does not automatically eliminate civil or disciplinary exposure in the patient's country.

13. Liability of Telemedicine Platforms

Digital platforms play an important role in international prescribing.

They may:

Connect foreign doctors with patients.

Collect medical questionnaires.

Process prescription requests.

Transmit electronic prescriptions.

Recommend pharmacies.

Facilitate international medicine delivery.

A platform may face legal exposure if it participates in unlawful prescribing or pharmaceutical distribution.

Potential grounds of liability include:

1. Negligent verification

Failure to verify the professional registration of doctors.

2. Misrepresentation

Advertising doctors as authorised to practise in a country when they are not.

3. Prescription facilitation

Knowingly facilitating prescriptions that violate applicable pharmaceutical laws.

4. Unsafe platform design

Failure to implement reasonable safeguards for patient identification, drug-interaction checks or prescription authentication.

5. Privacy violations

Improper transfer or disclosure of sensitive health information.

However, platform liability is not automatic. It depends on the platform's actual functions, applicable statutory provisions, knowledge, contractual arrangements and degree of involvement.

14. Data Protection and Cross-Border Prescription Records

Telemedicine prescriptions frequently involve international transfers of sensitive personal information.

Such information may include:

Patient identity.

Medical history.

Genetic information.

Psychiatric records.

Prescription history.

Drug allergies.

Diagnostic reports.

Treatment records.

Relevant legal frameworks include:

European Union: General Data Protection Regulation (GDPR), particularly its rules on health data and international transfers.

India: Digital Personal Data Protection Act, 2023, and applicable rules and commencement provisions.

United States: Health Insurance Portability and Accountability Act (HIPAA), where the relevant entities and activities fall within its scope.

United Kingdom: UK GDPR and Data Protection Act 2018.

The transfer of a prescription between countries must therefore be assessed independently from the legal validity of the prescription itself.

For example, a doctor may be legally entitled to prescribe a medicine but still violate data-protection requirements by transferring the patient's medical history to an unauthorised overseas pharmacy.

15. Cross-Border Recognition and Enforcement of Foreign Prescriptions

Recognition and enforcement are two different legal questions.

Recognition means accepting that a prescription issued abroad satisfies the requirements for consideration or dispensing under domestic law.

Enforcement means implementing the prescription through a legally authorised pharmacy or other regulated institution.

A foreign prescription may be recognised but still not dispensed because:

The medicine is unavailable.

The medicine is not authorised domestically.

The doctor lacks the required registration.

The prescription does not meet local formalities.

The medicine is controlled.

The pharmacy cannot verify its authenticity.

The European Union provides a more developed recognition framework through Directive 2011/24/EU and Implementing Directive 2012/52/EU.

However, recognition does not mean unrestricted cross-border access to every medicine. National rules on prescribing, dispensing and reimbursement continue to matter.

EUR-Lex+2

16. Major Regulatory Challenges

The principal regulatory challenges can be summarised as follows.

17. Important Legal Doctrines

Several legal doctrines are particularly important in resolving cross-border prescribing conflicts.

1. Territoriality doctrine

A country may regulate medical practice having a sufficient territorial connection with it.

2. Objective territoriality doctrine

Conduct occurring abroad may attract jurisdiction when it produces legally significant consequences within the forum.

3. Professional licensing doctrine

A medical qualification or licence from one jurisdiction does not automatically confer unrestricted professional rights elsewhere.

4. Patient-protection doctrine

Regulatory rules must protect patients against unsafe, unauthorised or misleading medical services.

5. Pharmaceutical sovereignty

Every country retains regulatory authority over the approval, importation, distribution and dispensing of medicines within its territory, subject to applicable international obligations.

6. Informed-consent doctrine

Patients must receive appropriate information about treatment risks and alternatives.

7. Reasonable-care doctrine

Remote prescribing must satisfy the applicable professional standard of care.

8. Regulatory cooperation doctrine

Countries should cooperate in verifying foreign medical registration, investigating misconduct and addressing unlawful pharmaceutical distribution.

18. Suggested International Regulatory Framework

A comprehensive framework for resolving cross-border telemedicine prescribing conflicts should contain the following safeguards.

1. Mutual recognition of medical registration: Establish limited recognition arrangements between participating countries.

2. Destination-country compliance: Require foreign practitioners to comply with essential prescribing requirements in the patient's jurisdiction.

3. International prescription authentication: Develop interoperable digital prescription systems.

4. Controlled-drug safeguards: Maintain additional verification and prohibit unlawful cross-border supply.

5. Medicine approval verification: Require confirmation that the prescribed medicine can lawfully be supplied in the destination country.

6. Professional indemnity insurance: Require adequate coverage for cross-border clinical activities.

7. Regulatory cooperation: Enable medical councils and pharmaceutical regulators to exchange information about serious violations.

8. Patient complaint mechanisms: Provide accessible procedures for patients to complain against foreign telemedicine practitioners.

9. Data protection: Require appropriate safeguards for international health-data transfers.

10. Platform accountability: Require platforms to verify practitioners and maintain reliable prescription records.

11. Emergency referral arrangements: Establish procedures for patients who require immediate physical examination or hospital treatment.

12. Clear choice-of-law provisions: Clarify the applicable law for professional negligence, contractual disputes and consumer claims without excluding mandatory local protections.

19. Critical Legal Analysis

Cross-border telemedicine prescribing exposes a fundamental weakness in conventional medical regulation: medical licensing remains predominantly territorial, whereas healthcare delivery increasingly operates through international digital networks.

Three competing interests must be balanced.

First, freedom of access to healthcare.

Patients should be able to access specialists and medical expertise located in other countries.

Second, national regulatory sovereignty.

Countries must retain the ability to control medical practice, medicine approval and pharmaceutical distribution within their territories.

Third, patient safety and accountability.

Patients must have meaningful remedies when foreign medical practitioners issue negligent, unauthorised or dangerous prescriptions.

The decision in Hageseth v. Superior Court demonstrates the importance of the destination country's regulatory interests. Conversely, the EU's cross-border prescription framework illustrates how mutual recognition can facilitate patient access without removing national safeguards.

For India, the major challenge is the absence of a comprehensive framework specifically designed to resolve international telemedicine prescribing conflicts. The 2020 guidelines provide an important domestic foundation, but they do not establish a general international licensing or prescription-recognition system.

A future framework should distinguish between overseas second opinions, direct patient consultations, independent diagnosis, prescription issuance and cross-border dispensing. These activities should not automatically be treated as legally identical.

20. Conclusion

Cross-border telemedicine prescribing conflicts arise because medical licensing, pharmaceutical regulation, electronic prescriptions and professional accountability operate under different national legal systems.

A doctor authorised to prescribe in one country cannot automatically assume that the prescription is lawful in the patient's country. Similarly, the electronic transmission of a prescription does not remove the destination country's authority over medicine importation, dispensing and patient protection.

The most significant judicial authority is Hageseth v. Superior Court (2007), which demonstrates that internet-based prescribing may create criminal jurisdiction in the patient's state even when the doctor remains physically abroad.

The Indian decisions in Jacob Mathew and Indian Medical Association v. V.P. Shantha provide important foundations for professional negligence and consumer protection. The European recognition framework provides a useful comparative model.

Ultimately, effective international telemedicine regulation requires coordinated medical licensing, pharmaceutical controls, electronic prescription recognition, patient remedies and cross-border regulatory cooperation.

21. Important Case Law Revision Table

22. Important Legislative and International References

National Medical Commission Act, 2019 (India).

Telemedicine Practice Guidelines, 2020 (India).

Drugs and Cosmetics Act, 1940 (India).

Drugs Rules, 1945 (India).

Narcotic Drugs and Psychotropic Substances Act, 1985 (India).

Consumer Protection Act, 2019 (India).

Digital Personal Data Protection Act, 2023 (India).

Health Practitioner Regulation National Law (Australia).

Health Insurance Portability and Accountability Act (USA).

General Data Protection Regulation (EU).

Directive 2011/24/EU on patients' rights in cross-border healthcare.

Commission Implementing Directive 2012/52/EU.

Single Convention on Narcotic Drugs, 1961.

Convention on Psychotropic Substances, 1971.

23. Primary Research Sources

Hageseth v. Superior Court (2007) – Full judgment

India – Telemedicine Practice Guidelines, 2020

Medical Board of Australia – Telehealth consultations

EU Directive 2011/24/EU – Article 11

EU cross-border ePrescription guidelines

Smits and Peerbooms – C-157/99

Research note: The cases on medical negligence, informed consent and cross-border healthcare discussed above establish relevant legal principles; they should not all be described as direct decisions on international telemedicine prescriptions. This distinction is important in academic writing and legal submissions.